These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 4570617

  • 21. The hepatic porphyrias.
    Romeo G.
    Prog Med Genet; 1980; 4():169-97. PubMed ID: 7003654
    [No Abstract] [Full Text] [Related]

  • 22. Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs.
    Abbritti G, De Matteis F.
    Chem Biol Interact; 1972 Mar; 4(4):281-6. PubMed ID: 5008942
    [No Abstract] [Full Text] [Related]

  • 23. [Congenital erythropoietic porphyria].
    Simard H, Barry A, Villeneuve B, Petitclerc C, Garneau R, Delâge JM.
    Can Med Assoc J; 1972 May 06; 106(9):1002 passim. PubMed ID: 5026730
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical biochemistry: emphasis on porphyria].
    Doss M.
    Fortschr Med; 1977 Nov 10; 95(42):2517-8, 2537. PubMed ID: 914208
    [No Abstract] [Full Text] [Related]

  • 25. [Diagnosis of porphyrin metabolism disorders].
    Raab W.
    Med Klin; 1969 Oct 24; 64(43):1993-9. PubMed ID: 5361971
    [No Abstract] [Full Text] [Related]

  • 26. Porphyria. Case presentations. Case 3: M.A., non-white female, 26 years.
    Gordon W.
    S Afr Med J; 1971 Sep 25; ():240. PubMed ID: 5150289
    [No Abstract] [Full Text] [Related]

  • 27. Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect.
    Felsher BF, Kushner JP.
    Semin Hematol; 1977 Apr 25; 14(2):243-51. PubMed ID: 323986
    [No Abstract] [Full Text] [Related]

  • 28. [Disturbances of metabolism in experimental porphyrias].
    Panfil B.
    Postepy Hig Med Dosw; 1969 Apr 25; 23(3):275-91. PubMed ID: 4896416
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of the porphyrias: mechanisms of action.
    Bickers DR.
    J Invest Dermatol; 1981 Jul 25; 77(1):107-13. PubMed ID: 7252241
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Studies on porphyrin biosynthesis and enzymes involved in bovine congenital erythropoietic porphyria.
    Del Batlle AM, De Xifra EA, Stella AM, Bustos N, With TK.
    Clin Sci (Lond); 1979 Jul 25; 57(1):63-70. PubMed ID: 477249
    [No Abstract] [Full Text] [Related]

  • 34. On the apparent existence of Günther's haematoporphyria acuta toxica and acquired acute porphyria.
    Hoo TT.
    S Afr Med J; 1971 Sep 25; ():137-9. PubMed ID: 5150266
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Congenital erythropoietic porphyria. An autopsy report.
    Bhutani LK, Sood SK, Das PK, Mulay DN, Kandhari KC, Deshpande SG.
    Arch Dermatol; 1974 Sep 25; 110(3):427-31. PubMed ID: 4451391
    [No Abstract] [Full Text] [Related]

  • 37. [Congenital erythropoietic porphyria (Gunther's disease). A case diagnosed at birth].
    Martin C, Babin JP, Sanjuan B, Demarquez JL, Dubernet C, Maillet-Mezeray G.
    Nouv Presse Med; 1973 Nov 03; 2(39):2591-4. PubMed ID: 4793420
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Recent advances in porphyrin metabolism.
    Pindyck J, Kappas A, Levere RD.
    CRC Crit Rev Clin Lab Sci; 1971 Nov 03; 2(4):639-57. PubMed ID: 4944524
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.